04-06-11 Links to 6 New HCV Articles/Press Releases

[Guest guest]

2 new hepatitis C treatments promise a possible cure

Detroit Free Press

The 170000 Americans newly diagnosed each year with hepatitis C soon are

expected to have two new drug-treatment options that promise a possible cure

from the liver disease. Both Merck & Co. of Whitehouse Station, NJ,. and Vertex

Pharmaceuticals of ...

See all stories on this topic »

Hepatitis C drugs could be cure

The Tennessean

Boceprevir once a day, or telaprevir two or three times a day to stop hepatitis

C from replicating. “We're closing in on a cure,” said Dr. Stuart Gordon, a

hepatitis C researcher at Henry Ford Hospital in Detroit. Gordon coauthored one

of the drug ...

See all stories on this topic »

Vertex's Telaprevir Impresses Again

Zacks.com

Both trials were conducted to evaluate telaprevir in combination with

pegylated-interferon and ribavirin as a treatment for chronic hepatitis C. The

REALIZE study was conducted with chronic hepatitis C patients whose prior

treatment with ...

See all stories on this topic »

Adding New Drug Boceprevir Can Help Treat Hepatitis C

Becker's ASC Review

By Jaimie Oh | April 05, 2011 Researchers suggest adding a new drug boceprevir

to a two-drug treatment can enhance outcomes for hepatitis C patients, according

to a USA Today news report. The drugs currently used to treat hepatitis C are

Copegus, ...

See all stories on this topic »

Boehringer Ingelheim to commence phase III trial of hepatitis C drug

Zenopa

Boehringer Ingelheim has announced plans to move ahead with phase III clinical

trials of its new hepatitis C treatment BI 201335. The company has provided an

outline for the forthcoming placebo-controlled studies, which will evaluate the

once-daily ...

See all stories on this topic »

Hepatitis C, Alcohol Use and Nonalcoholic Fatty Liver Disease Greatest Risk ...

Becker's ASC Review

By Jaimie Oh | April 05, 2011 Research suggests risk factors for hepatocellular

carcinoma may include hepatitis C virus, alcohol use and nonalcoholic fatty

liver disease, according to a study published in Clinical Gastroenterology and

Hepatology. ...

See all stories on this topic »